Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b…
Øivind Hundal, Eva Biringer, Inge Losnegard, Anders Lund
Objective : Patients with diabetes have an increased Odds Ratio (OR) for depressive disor- der. We wanted to investigate if patients with metabolic syndrome and/or diabetes type 2 not treated with antidiabetic agents, have an OR for concurrent antidepressant…
Sirima Mongkolsomlit, Petch Rawdaree, Chulalux Komoltri, Chamaiporn Tawichasri, Jayanton Patumanond
Objective: To develop and validate a prognostic scoring scheme for the prediction of microalbuminuria in type 2 diabetic patients of Thai descent. Methods: The clinical information from type 2 diabetic patients who were treated at community hospitals was used…
Maria Pia de la Maza, Fernando Garrido, Nadia Escalante, Laura Leiva, Gladys Barrera, Sylvia Schnitzler, Mario Zanolli, Juan Verdaguer, Sandra Hirsch, Natallia Jara, Daniel Bunout
BACKGROUND: Advanced glycation end-products (AGEs) are one of the mechanisms related to diabetic vascular complications. However, since AGEs are multiple and heterogeneous moieties, there is no universally accepted method to measure them for clinical purposes…
Menghua Luo, Anne C. Voss, Vikkie A. Mustad, Lyudmila Ivanova, Tatiana Morugova, Elena Alexeeva, Lyudmila Ruyatkina, Lyudmila Suplotova
Background: Postprandial hyperglycemia is an independent risk factor for diabetes-associated complications in individuals with type 2 diabetes. Dietary modification plays an important role in glycemic control. This study was to examine the efficacy of a diabe…
M. V. Chandrakanth, Sidhartha Das, Shashi Bhusan Rout, Rina Mohanty, Sharat Chandra Singh, Madhusmita Pattnaik, Bibuthi Sethy
Objectives: The present study was designed to assess the markers of atherosclerosis including Insulin resistance (IR) in na?ve patients with chronic renal failure (CRF). Methods: Eighty consecutive na?ve patients with CRF were taken up for study. They were di…
Mark R. Burge, Eric R. Schroeder, Stephen Mitchell
Objective: Evidence supporting the twice-daily administration of insulin glargine as an approach to address its waning effectiveness at the end of a 24 hour period is sparse. We hypothesized that insulin concentrations determined during the last four hours of…
Xinhua Chen, Theresa O. Scholl, T. Peter Stein
Objective: The aims of this study were to examine the influence of maternal hypoadiponectinemia on the risk of varying degrees of gestational hyperglycemia as well as on ethnic differences in circulating levels of adiponectin. Methods: A case-control study ne…
Goutameswar Mazumdar, Bikash Swaika, Anindya Dasgupta
Introduction: Management of hyperglycemia in type2 diabetes mellitus (T2DM) becomes the top priority. When single antidiabetic drug is ineffective, combination is required for good glycemic control. There is a dearth of studies that provide head to head compa…
Patrizio Tatti, Desiderio Passali, Luisa Passali
Up to recently the respiratory disturbances were considered a risk factor for hypertension, but there was no trace of a role in metabolic disorders. Only recently the existence of a connection among the respiratory disturbance caused by the obstruction of the…
Kadhim Ali Kadhim, Dowser Khalil Ismael, Ban Hoshi Khalaf, Khalid Ibrahim Hussein, Munaf Hashim Zalzala, Saad Abdulrahman Hussain
Despite the extensive clinical experience with the use of metformin worldwide, no formal dose-ranging study has been conducted because the current dosing strategy of metformin was determined empirically, rather than by an understanding of its dose-response re…
No articles in this issue.
JDM is an international journal dedicated to the current developments of Diabetes Mellitus, the broad scope will also include significant research in the fields of pathology and therapeutic innovations of diabetes itself, both type I and II. All manuscripts submitted to JDM must be previously unpublished and may not b… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).